Pneumococcal vaccine conjugate 13-valent (Beijing Minhai Biotechnology)

13价肺炎球菌结合疫苗（北京民海生物）

Report date: 2025/04/01 14:27:21

Base Information

Drug NamePneumococcal vaccine conjugate 13-valent (Beijing Minhai Biotechnology)
Drug Alias Name13-valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)13价肺炎球菌多糖结合疫苗（破伤风类毒素/白喉类毒素）PCV13-DT/TT VaccinePneuminvac
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumoniaPneumococcal Infections
Global Approved IndicationsPneumonia
Approved Indications in ChinaPneumonia
Original Approved Country/TerritoryMainland China
Original Approved Date2021/09/07
Country/TerritoryIndonesiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Minhai Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Minhai Biotechnology Co LtdBiotis Pharmaceuticals IndonesiaShenzhen Kangtai Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumoniaPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ07AL
Related LinksN/A